MOLLY WILCOX: Open Payments
NPI 1639958192 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 14 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $405
Food & beverage: $306Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $256 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $77 |
| Ardelyx, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: TREMFYA, XIFAXAN, IBSRELA, RINVOQ, ENTYVIO.
Industry payments across DC — which companies pay providers there.
